作者：
Raymond L,Benza [1]
;
Athénaïs,Boucly [2]
;
Harrison W,Farber [3]
;
Adaani E,Frost [4]
;
Hossein-Ardeschir,Ghofrani [5]
;
Marius M,Hoeper [6]
;
Marc,Lambelet [7]
;
Claudia,Rahner [7]
;
Sameer,Bansilal [8]
;
Sylvia,Nikkho [9]
;
Christian,Meier [10]
;
Olivier,Sitbon [2]
作者单位：
Department of Medicine, The Ohio State University Wexner Medical Center, Columbus, Ohio. Electronic address: Raymond.Benza@osumc.edu.
[1]
Université Paris-Saclay, Faculté de Médecine, Le Kremlin-Bicêtre, France; AP-HP, Service de Pneumologie, Hôpital Bicêtre, Le Kremlin-Bicêtre, France; INSERM UMR_S 999, Hôpital Marie Lannelongue, Le Plessis Robinson, France.
[2]
Pulmonary Hypertension Center, Boston University/Boston Medical Center, Boston, Massachusetts.
[3]
Houston Methodist Research Institute, Houston Methodist Hospital, Houston, Texas.
[4]
Department of Medicine, University of Giessen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), Giessen, Germany; Imperial College London, London, UK; Department of Pneumology, Kerckhoff-Klinik, Bad Nauheim, Germany.
[5]
Department of Respiratory Medicine and the German Center for Lung Research, Hannover Medical School, Hannover, Germany.
[6]
Chrestos Concept GmbH & Co. KG, Essen, Germany.
[7]
US Medical Affairs, Bayer Corporation, Whippany, New Jersey.
[8]
Global Clinical Development, Bayer AG, Berlin, Germany.
[9]
Global Medical Affairs, Bayer AG, Berlin, Germany.
[10]
DOI
10.1016/j.healun.2021.10.013
PMID
34848133
发布时间
2022-03-31
换一批
换一批
